Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitaxentan for bronchial remodeling in severe asthma with fixed airflow obstruction
2007-007481-38Phase 3Terminated
- Sponsor
- Inserm
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pirfenidone in asthma (2 arms), sponsored by Inserm. Primary endpoints: Change in bronchial smooth muscle area and Change in submucosal fibroblast number. Started Mar 2008; status: terminated.
02
Drugs
pirfenidone
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-007481-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007481-38.